ARCHIVES

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Four Center Grants In Danger; Shingleton to Retire, Owen Promoted At Hopkins

January 9, 1987

In Brief: Ahoy! It’s “Admiral Rick”

April 2, 1999

House Disallows NCI Recision

March 14, 1975

NCI Intramural Programs: Clinical Trials Support System Need Attention, report Advises DCS

December 19, 1997

Novel Antifungal Agent Highly Active Against Esophageal Candidiasis

October 31, 2003

Saffiotti Quits As Carcinogenesis Chief With Blast At Rauscher, Peters

April 30, 1976